Your browser doesn't support javascript.
loading
A T-cell engaging bispecific antibody with a tumor-selective bivalent folate receptor alpha binding arm for the treatment of ovarian cancer.
Avanzino, Brian C; Prabhakar, Kirthana; Dalvi, Pranjali; Hartstein, Sharon; Kehm, Hannes; Balasubramani, Aarti; Boudreau, Andrew A; Buelow, Ben; Chang, Karen; Davison, Laura M; Iyer, Suhasini; Kalwit, Vidyut; Lewis Wilson, Kristin; Malik-Chaudhry, Harbani K; Pierson, Will; Pineda, Geovanni; Rangaswamy, Udaya S; Saiganesh, Sowmya; Schellenberger, Ute; Ugamraj, Harshad S; Yabut, Rodolfovan D; Buelow, Roland; Chapman, Jocelyn; Trinklein, Nathan D; Harris, Katherine E.
Afiliação
  • Avanzino BC; Teneobio, Inc, Newark, CA, United States.
  • Prabhakar K; Oncology Research, Amgen Inc., Newark, CA, USA.
  • Dalvi P; Teneobio, Inc, Newark, CA, United States.
  • Hartstein S; Oncology Research, Amgen Inc., Newark, CA, USA.
  • Kehm H; Teneobio, Inc, Newark, CA, United States.
  • Balasubramani A; Oncology Research, Amgen Inc., Newark, CA, USA.
  • Boudreau AA; Teneobio, Inc, Newark, CA, United States.
  • Buelow B; Therapeutic Discovery, Amgen Inc., Newark, CA, USA.
  • Chang K; Teneobio, Inc, Newark, CA, United States.
  • Davison LM; Teneobio, Inc, Newark, CA, United States.
  • Iyer S; Therapeutic Discovery, Amgen Inc., Newark, CA, USA.
  • Kalwit V; Teneobio, Inc, Newark, CA, United States.
  • Lewis Wilson K; Teneobio, Inc, Newark, CA, United States.
  • Malik-Chaudhry HK; Teneobio, Inc, Newark, CA, United States.
  • Pierson W; Teneobio, Inc, Newark, CA, United States.
  • Pineda G; Teneobio, Inc, Newark, CA, United States.
  • Rangaswamy US; Teneobio, Inc, Newark, CA, United States.
  • Saiganesh S; Oncology Research, Amgen Inc., Newark, CA, USA.
  • Schellenberger U; Translational Safety & Bioanalytical Sciences, Amgen Inc., South San Francisco, CA, USA.
  • Ugamraj HS; Teneobio, Inc, Newark, CA, United States.
  • Yabut RD; Therapeutic Discovery, Amgen Inc., Newark, CA, USA.
  • Buelow R; Division of Gynecologic Oncology, University of California, San Francisco, CA, USA.
  • Chapman J; University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
  • Trinklein ND; Division of Gynecologic Oncology, University of California, San Francisco, CA, USA.
  • Harris KE; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
Oncoimmunology ; 11(1): 2113697, 2022.
Article em En | MEDLINE | ID: mdl-36016696
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Anticorpos Biespecíficos Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Anticorpos Biespecíficos Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article